Abstract:Objective: To investigate the clinical phenotypes and the mutant allele proportion of parents with SCN1A gene mutation mosaicism of Dravet syndrome (DS) children, thus to provide guidance for family reproduction and prenatal diagnosis. Method: The clinical data and peripheral blood DNA samples of DS patients with a SCN1A gene mutation proved by Sanger sequencing were collected prospectively from February 2005 to November 2016 in Department of Pediatrics, Peking University First Hospital. The same mutation was searched in parents and other available relatives. Parental somatic mosaicism was confirmed and quantified by Ion Torrent Personal Genome Machine (PGM) and Raindrop droplet digital PCR (ddPCR). The families were followed up and prenatal diagnosis was provided. Result: Mosaicisms of SCN1A gene mutation in parents were identified in 5.2% (30 out of 575) DS families. Seventeen were fathers and thirteen were mothers. The mutant allele proportion ranged from 1.7% to 32.9% by PGM and from 0.82% to 34.51% by ddPCR, respectively. In 30 parents with somatic mosaicism, thirteen were asymptomatic, ten had a history of febrile seizures (FS), five with epilepsy, one with febrile seizure plus and one had a history of afebrile seizure. Four families had two children with DS. Three siblings of the probands were confirmed genetically with the same pathogenic mutation. One deceased sister of the proband was assumed to have the same pathogenic mutation because she matched DS diagnosis after medical history review despite no blood sample. Two families received prenatal diagnosis. One second pregnancy was terminated because the fetus inherited the mutation as the mother's wish. Conclusion: Sanger sequencing detects parents of some children with DS are SCN1A mutation mosaics. PGM and ddPCR can be used for accurate quantification of mutant mosaics, which can provide accurate guidance for family genetic counseling.

Amplicon Resequencing Identified Parental Mosaicism for Approximately 10% of “ De Novo ” SCN1A Mutations in Children with Dravet Syndrome

Clinical and Molecular Analysis of Epilepsy-Related Genes in Patients with Dravet Syndrome

[Study on Mosaicism of SCN1A Gene Mutation in Parents of Children with Dravet Syndrome].

Parental Mosaicism Detection and Preimplantation Genetic Testing in Families with Multiple Transmissions of De Novo Mutations.

Genomic Mosaicism in Paternal Sperm and Multiple Parental Tissues in a Dravet Syndrome Cohort

Dravet syndrome with favourable cognitive and behavioral development due to a novel SCN1A frameshift mutation

Low-level germline mosaicism of a novel <i>SMARCA2</i> missense variant: Expanding the phenotypic spectrum and mode of genetic transmission

Analysis of SCN1A mutation and parental origin in patients with Dravet syndrome

Analysis of parental origin of de novo SCN1A mutations in Dravet syndrome

Assessment of parental mosaicism rates in neurodevelopmental disorders caused by apparent de novo pathogenic variants using deep sequencing

[Genetic and phenotypic characteristics of SCN1A mutations in Dravet syndrome].

Detecting Genomic Mosaicism in “de Novo” Genetic Epilepsy by Amplicon-Based Deep Sequencing

Mosaicism of a Missense SCN1A Mutation and Dravet Syndrome in a Roma/Gypsy Family

Mosaic SCN1A Mutations in Familial Partial Epilepsy with Antecedent Febrile Seizures

[Analysis of SCN1A Deletions or Duplications in Patients with Dravet Syndrome].

Parental Mosaicism in De Novo Neurodevelopmental Diseases

Postzygotic Single-Nucleotide Mosaicisms in Whole-Genome Sequences of Clinically Unremarkable Individuals.

Case Report: Identification of Maternal Low-Level Mosaicism in the Dystrophin Gene by Droplet Digital Polymerase Chain Reaction

Phenotype and gene mutation screening in familial Dravet syndrome

Identification of of a PAX2 Mutation from Maternal Mosaicism Causes Recurrent Renal Disorder in Siblings

Paternal Low-Level Mosaicism-Caused SATB2-Associated Syndrome